Interpretation of pediatric endocrine laboratory tests: Pitfalls in steroid hormone measurements and genotyping

Pediatric Endocrinology Reviews

Volumn 5, Issue SUPPL. 1, 2007, Pages 578-583

  Speiser, Phyllis W ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

Adrenal cortex; Mass spectrometry; Radioimmunoassay; Steroids

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CYTOCHROME P450 REDUCTASE; HYDROXYPROGESTERONE; PRASTERONE SULFATE; STEROID; TESTOSTERONE;

ADRENAL DISEASE; ADRENAL HYPERPLASIA; ANAMNESIS; BODY HEIGHT; BODY WEIGHT; CIRCADIAN RHYTHM; CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; ENDOCRINE DISEASE; GENOTYPE; HEALTH CARE SYSTEM; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MENARCHE; NEWBORN SCREENING; PHENOTYPE; PHYSICAL EXAMINATION; PRIMARY HEALTH CARE; PROVOCATION TEST; RADIOIMMUNOASSAY; REVIEW;

ADRENAL HYPERPLASIA, CONGENITAL; CHILD; ENDOCRINE SYSTEM DISEASES; FALSE POSITIVE REACTIONS; FEMALE; GENOTYPE; GONADAL STEROID HORMONES; HUMANS; IMMUNOASSAY; INFANT, NEWBORN; NEONATAL SCREENING; PEDIATRICS; PUBERTY, PRECOCIOUS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STEROID 17-ALPHA-HYDROXYLASE; STEROID 21-HYDROXYLASE; TESTOSTERONE;

EID: 36049048947     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Korth-Schutz S, Levine LS, New MI. Serum androgens in normal prepubertal and pubertal children and in children with precocious adrenarche. J Clin Endocrinol Metab 1976;42(1):117-124
2. Mayer SK, Oligny LL, Deal C, Yazbeck S, Gagne N, Blanchard H. Childhood adrenocortical tumors: case series and reevaluation of prognosis-a 24-year experience. J Pediatr Surg 1997;32(6):911-915
3. Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, Levy D, Lerner AJ, Rondanini GF, Dupont B, New MI. Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 1982;55(5):817-827
4. Zerah M, Pang SY, New MI. Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 1987;65(2):227-232
5. Vining RF, McGinley RA, Symons RG. Hormones in saliva: mode of entry and consequent implications for clinical interpretation. Clin Chem 1983;29(10):1752-1756
6. Lac G. Saliva assays in clinical and research biology. Pathol Biol (Paris) 2001;49(8):660-667
7. Arlt W, Walker EA, Draper N et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 2004;363(9427):2128-2135
8. Shackleton C, Marcos J, Malunowicz EM, Szarras-Czapnik M, Jira P, Taylor NF, Murphy N, Crushed E, Gottschalk M, Hauffa B, Cragun DL, Hopkin RJ, Adachi M, Arlt W. Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis. Am J Med Genet A 2004;128(3):223-231
9. Shackleton CH, Marcos P. GC/MS steroid profiling: Diagnosis of disorders affecting steroid synthesis and metabolism. In: Gross M, Caprioli R, editors. The Encyclopedia of Mass Spectrometry, Volume 8 Oxford. Elsevier 2006:789-813
10. Wudy SA, Hartmann MF, Draper N, Stewart PM, Arlt W. A mate twin infant with skull deformity and elevated neonatal 17-hydroxyprogesterone: a prismatic case of P450 oxidoreductase deficiency. Endocr Res 2004;30(4):957-964
11. de Weerth, Zijl RH, Buitelaar JK. Development of Cortisol circadian rhythm in infancy. Early Hum Dev 2003;73(1-2):39-52
12. Papanicolaou DA, Mullen N, Kyrou I, Nieman LK. Nighttime salivary Cortisol: A useful test for the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 2002;87(10):4515-4521
13. Yaneva M, Mosnier-Pudar H, Dugue MA, Grabar S, Fulla Y, Bertagna X. Midnight salivary Cortisol for the initial diagnosis of Cushing's syndrome of various causes. J Clin Endocrinol Metab 2004;89(7):3345-3351
14. Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A. Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, testosterone and estradiol secretion before the onset of female puberty in short children. J Clin Endocrinol Metab 2000;85(3):1074-1080
15. Selvage DJ, Parsons L, Rivier C. Role played by brainstem neurons in regulating testosterone secretion via a direct neural pathway between the hypothalamus and the testes. Endocrinology 2006;147(6):3070-3075
16. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on Cortisol levels and Cortisol response to corticotropin. JAMA 2000;283(8):1038-1045
17. Rady MY, Johnson DJ, Patel B, Larson J, Helmers R. Cortisol levels and corticosteroid administration fail to predict mortality in critical illness: the confounding effects of organ dysfunction and sex. Arch Surg 2005;140(7):661-668
18. Menon K, Clarson C. Adrenal function in pediatric critical illness. Pediatr Crit Care Med 2006;3(2):112-116
19. Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med 1997;337(18):1285-1292
20. Efird MM, Heerens AT, Gordon PV, Bose CL, Young DA. A randomized controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants. J Perinatal 2006;25(2):119-124
21. Sharma M. Effects of drugs on endocrine function and values. In: Becker KL, editor, Principles and Practice of Endocrinology and Metabolism. PhHa: LWW 2001;2232-2252
22. Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem 1994;40(11 Pt 1):1996-2005
23. Wong T, Shackleton CH, Covey TR, Ellis G. Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays. Clin Chem 1992;38(9):1830-1837
24. Andrew R. Clinical measurement of steroid metabolism. Best Pract Res Clin Endocrinol Metab 2001;15(1):1-16
25. Fuqua JS, Sher ES, Migeon CJ, Berkovitz GD. Assay of plasma testosterone during the first six months of life: importance of chromatographic purification of steroids. Clin Chem 1995;41(8 Pt 1):1146-1149
26. White PC. Ontogeny of adrenal steroid biosynthesis: why girls will be girls. J Clin Invest 2006;116(4):872-874
27. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C, Boudou P. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women and children. Clin Chem 2003;49(8):1381-1395
28. Taieb J, Benattar C, Birr AS, Lindenbaum A. Limitations of steroid determination by direct immunoassay. Clin Chem 2002;48(3):583-585
29. Klein KO, Baron J, Colli MJ, McDonnell DP, Cutler GB, Jr. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 1994;94(6):2475-2480
30. Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med 2005;353(24):2578-2588
31. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 2004;89(2):525-533
32. Wang C, Cattin DH, Demers LM, Starcevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2004;89(2):534-543
33. Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P, Matern D. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 2004;89(8):3687-3693
34. Kushnir MM, Rockwood AL, Roberts WL Pattison EG, Owen WE, Bunker AM, Meikle AW. Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. Clin Chem 2006;52(8):1559-1567
35. Rauh M, Groschl M, Rascher W, Dorr HG. Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone androstenedione and testosterone by tandem mass spectrometry with on-line extraction. Steroids 2006;71(6):450-458
36. Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW, Day DJ. Genotyping of CYP21, linked chromosome 6p markers and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1999;84(3):960-966
37. Nordenstrom A, Thilen A, Hagenfeldt L, Larsson A, Wedell A. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999;84(5):1505-1509
38. Day DJ, Speiser PW, Schulze E, Bettendorf M, Fitness J, Barany F, White PC. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet 1996;5(12):2039-2048
39. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21(3):245-291
40. White PC, Vitek A, Dupont B, New MI. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A 1988;85(12):4436-4440
41. Keen-Kim D, Redman JB, Alanes RU, Eachus MM, Wilson RC, New MI, Nakamoto JM, Fenwick RG. Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency). J Mol Diagn 2005;7(2):236-246
42. Speiser PW, Dupont J, Zhu D Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI, White PC. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992;90(2):584-595
43. The Human Gene Mutation Database. http://archive.uwcm.ac.uk/uwcm/mg/ search/120605.html. 2006 Ref Type: Internet Communication
44. Peterson RE, Imperato-McGinley J, Gautier T, Shackleton C. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. N Engl J Med 1985;313(19):1182-1191
45. Shackleton C, Malunowicz E. Apparent pregnene hydroxylation deficiency (APHD): seeking the parentage of an orphan metabolome. Steroids 2003;68(9):707-717
46. Fukami M, Hasegawa T, Horikawa R, Ohashi T, Nishimura G, Homma K, Ogata T. Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis. Pediatr Res 2006;59(2):276-280
47. Pandey AV, Fluck CE, Huang N, Tajima T, Fujieda K, Miller WL. P450 oxidoreductase deficiency: a new disorder of steroidogenesis affecting all microsomal P450 enzymes. Endocr Res 2004;30(4):881-888
48. Therrell BL. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001;30(1):15-30
49. Rohrer TR, Gassmann KF, Pavel ME, Dorr HG. Pitfall of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Biol Neonate 2003;83(1):65-68
50. CAH newborn screening algorithm http://www.acmg.net/resources/policies/ ACT/Visio-NBS_Elevated-17OHP_4-18-06.pdf. 8-9-2006 Ref Type: Internet Communication
51. Guo T, Chan M, Soldin SJ. Steroid profiles using liquid chromatography-tandem mass spectrometry with atmospheric pressure photoionization source. Arch Pathol Lab Med 2004;128(4):469-475